NO20021437L - Fremgangsmate til forebyggelse av colorektal kreft - Google Patents

Fremgangsmate til forebyggelse av colorektal kreft

Info

Publication number
NO20021437L
NO20021437L NO20021437A NO20021437A NO20021437L NO 20021437 L NO20021437 L NO 20021437L NO 20021437 A NO20021437 A NO 20021437A NO 20021437 A NO20021437 A NO 20021437A NO 20021437 L NO20021437 L NO 20021437L
Authority
NO
Norway
Prior art keywords
cancer
prevention
prostate
bladder
lung
Prior art date
Application number
NO20021437A
Other languages
English (en)
Other versions
NO330061B1 (no
NO20021437D0 (no
Inventor
Hans Henrik Raskov
Original Assignee
Hans Henrik Raskov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hans Henrik Raskov filed Critical Hans Henrik Raskov
Publication of NO20021437D0 publication Critical patent/NO20021437D0/no
Publication of NO20021437L publication Critical patent/NO20021437L/no
Publication of NO330061B1 publication Critical patent/NO330061B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO20021437A 1999-09-29 2002-03-22 Farmasoytisk medikament og anvendelse derav for forebyggelse av colorektal kreft NO330061B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901390 1999-09-29
PCT/DK2000/000546 WO2001022974A1 (en) 1999-09-29 2000-09-29 Prevention of colorectal cancer

Publications (3)

Publication Number Publication Date
NO20021437D0 NO20021437D0 (no) 2002-03-22
NO20021437L true NO20021437L (no) 2002-05-24
NO330061B1 NO330061B1 (no) 2011-02-14

Family

ID=8104340

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021437A NO330061B1 (no) 1999-09-29 2002-03-22 Farmasoytisk medikament og anvendelse derav for forebyggelse av colorektal kreft

Country Status (13)

Country Link
US (1) US7851461B2 (no)
EP (1) EP1220676B1 (no)
AT (1) ATE294585T1 (no)
AU (1) AU779996B2 (no)
CA (1) CA2385755C (no)
DE (1) DE60019947T2 (no)
DK (1) DK1220676T3 (no)
ES (1) ES2240159T3 (no)
IS (1) IS2488B (no)
NO (1) NO330061B1 (no)
NZ (1) NZ517978A (no)
PT (1) PT1220676E (no)
WO (1) WO2001022974A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
CA2385755C (en) 1999-09-29 2007-02-06 Colotech A/S Prevention of colorectal cancer
US20040071789A1 (en) * 2002-02-14 2004-04-15 Baron John A Calcium supplementation to reduce prostate cancer risk
PT1389122E (pt) * 2001-04-05 2009-12-23 Hans Henrik Raskov Prevenção do cancro epitelial
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
WO2011024208A1 (en) * 2009-08-24 2011-03-03 Colotech A/S Combination dosage form with acetylsalicylic acid, calcitriol and calcium
EP2515913A2 (en) * 2009-12-23 2012-10-31 Glycomyr Inc. Use of vitamin d glycosides and sulfates for treatment of disease
CA2865424A1 (en) 2011-02-28 2012-09-07 Rigshospitalet Copenhagen University Hospital Active vitamin d or analogs thereof for use in in vivo or in vitro fertilization

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0205025A1 (en) 1985-05-27 1986-12-17 Sumitomo Pharmaceuticals Company, Limited Fluorine derivatives of vitamin D3 and cell differentiation-inducing agents containing the same as an active ingredient
KR0144358B1 (ko) 1988-04-21 1998-07-15 피. 라이달 크리스텐슨 비타민 d 동족체
HU221008B1 (hu) 1991-11-07 2002-07-29 Research Institute For Medicine And Chemistry D-vitamin-származékok és azokat tartalmazó gyógyászati készítmények
GB9206648D0 (en) 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
GB9226877D0 (en) 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Chemical compounds
GB9309422D0 (en) 1993-05-07 1993-06-23 Res Inst Medicine Chem Chemical compounds
GB9314400D0 (en) 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
GB9315253D0 (en) 1993-07-23 1993-09-08 Res Inst Medicine Chem Chemical compounds
DE4334154C2 (de) 1993-10-01 1997-05-22 Schering Ag 2-Halogeno-1,25-dihydroxy-cholecalciferole und pharmazeutische Zusammensetzungen
EP0833664A1 (en) 1995-06-12 1998-04-08 G.D. SEARLE & CO. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations
US5948443A (en) * 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
US5770215A (en) * 1997-01-06 1998-06-23 Moshyedi; Emil Payman Multivitamin/vascular occlusion inhibiting composition
CA2385755C (en) 1999-09-29 2007-02-06 Colotech A/S Prevention of colorectal cancer

Also Published As

Publication number Publication date
US7851461B2 (en) 2010-12-14
NO330061B1 (no) 2011-02-14
AU779996B2 (en) 2005-02-24
IS2488B (is) 2008-12-15
PT1220676E (pt) 2005-08-31
DK1220676T3 (da) 2005-09-05
WO2001022974A1 (en) 2001-04-05
ATE294585T1 (de) 2005-05-15
ES2240159T3 (es) 2005-10-16
NZ517978A (en) 2003-11-28
US20040116393A1 (en) 2004-06-17
DE60019947T2 (de) 2006-02-02
CA2385755A1 (en) 2001-04-05
EP1220676A1 (en) 2002-07-10
NO20021437D0 (no) 2002-03-22
DE60019947D1 (de) 2005-06-09
EP1220676B1 (en) 2005-05-04
CA2385755C (en) 2007-02-06
AU7406300A (en) 2001-04-30
IS6317A (is) 2002-03-20

Similar Documents

Publication Publication Date Title
BRPI0207961A8 (pt) Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos.
BRPI0410503A (pt) uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
TW200612987A (en) Combination treatment for non-hematologic malignancies
ATE472551T1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
CY1110376T1 (el) Χρηση μιας συνθεσης που περιλαμβανει φορμοτερολη και βουδεσονιδη για την προληψη απο ή τη θεραπευτικη αντιμετωπιση μιας οξειας καταστασης ασθματος
MY143795A (en) Tetrahydropyridoindole derivatives
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
NO20021437L (no) Fremgangsmate til forebyggelse av colorektal kreft
EA200801731A1 (ru) Составы и способы лечения тробмоцитемии
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
BRPI0507482A (pt) combinação de (a) um inibidor de dna topoisomerase e (b) um inibidor de iap
MXPA04001912A (es) Aminobenzofenonas novedosas.
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
DE60233869D1 (de) Prävention von epithelzellkarzinom
BRPI0519006A2 (pt) uso de um inibidor de fbpase, kit de uma composiÇço farmacÊutica, uso de uma preparaÇço de biguanida e um inibidor de fbpase, agente terapÊutico para diabetes melito, e, combinaÇço de agentes terapÊuticos
SE0203817D0 (sv) New composition
ATE346080T1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
IS2392B (is) Sítalópram til að meðhöndla hækkaðan blóðþrýsting
PL1700597T3 (pl) Kompozycja farmaceutyczna do podawania na skórę, zawierająca łącznie ubidekarenon, despantenol oraz chlorheksydynę lub jej farmakologicznie dopuszczalną sól
NO20051879L (no) Anvendelse av proteintyrosinfosfataseinhibitorer til forhindring og/eller behandling av kreft
TNSN06068A1 (en) Pharmaceutical composition containing in association ubidecarenone, dexpanthenol and chlorhexidine or a pharmaceutically acceptable salt thereof for cutaneous application

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT POSTBOKS 1003 SENTRUM OSLO, 0

MM1K Lapsed by not paying the annual fees